About Bioanalytical Systems (NASDAQ:BASI)
Bioanalytical systems, Inc. is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology & Medical Research
- Sub-Industry: N/A
- Symbol: NASDAQ:BASI
- CUSIP: N/A
- Web: www.basinc.com
Capitalization:- Market Cap: $14.99 million
- Outstanding Shares: 8,238,000
Average Prices:- 50 Day Moving Avg: $1.70
- 200 Day Moving Avg: $1.62
- 52 Week Range: $0.60 - $2.42
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 22.75
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: $23.52 million
- Price / Sales: 0.64
- Book Value: $0.87 per share
- Price / Book: 2.09
Profitability:- EBITDA: $1.65 million
- Net Margins: -5.88%
- Return on Equity: -20.72%
- Return on Assets: -6.61%
Debt:- Debt-to-Equity Ratio: 0.60%
- Current Ratio: 0.64%
- Quick Ratio: 0.51%
Misc:- Average Volume: 34,186 shs.
- Beta: 1.35
- Short Ratio: 0.25
Frequently Asked Questions for Bioanalytical Systems (NASDAQ:BASI)
What is Bioanalytical Systems' stock symbol?
Bioanalytical Systems trades on the NASDAQ under the ticker symbol "BASI."
How were Bioanalytical Systems' earnings last quarter?
Bioanalytical Systems, Inc. (NASDAQ:BASI) issued its quarterly earnings data on Monday, August, 14th. The company reported $0.03 EPS for the quarter. The company earned $5.84 million during the quarter. Bioanalytical Systems had a negative net margin of 5.88% and a negative return on equity of 20.72%. View Bioanalytical Systems' Earnings History.
When will Bioanalytical Systems make its next earnings announcement?
Who are some of Bioanalytical Systems' key competitors?
Some companies that are related to Bioanalytical Systems include OncoSec Medical Incorporated (ONCS), Burcon NutraScience Corp (BUR), Achieve Life Sciences (ACHV), Jaguar Animal Health (JAGX), OpGen (OPGN), Repros Therapeutics (RPRX), Senestech (SNES), Oxford Pharmascience Group Plc (OXP), Transgenomic (PRPO), RXi Pharmaceuticals Corporation (RXII), Novogen Limited (NVGN), Metabolix (YTEN), Ampliphi Biosciences Corp (APHB), Synairgen plc (SNG), Ixico Plc (IXI), Roka Bioscience (ROKA), Akers Biosciences (AKR) and Prana Biotechnology Ltd (PRAN).
Who are Bioanalytical Systems' key executives?
Bioanalytical Systems' management team includes the folowing people:
- Gregory C. Davis Ph.D., Interim Chairman of the Board
- Jill Blumhoff, Chief Financial Officer, Vice President - Finance
- James S. Bourdage Ph.D., Vice President - Bioanalytical Operations
- Philip A. Downing, Vice President - Preclinical Services
- Connie Dougherty, Vice President - Business Development
- Richard Allen Johnson Ph.D., Independent Director
- R. Matthew Neff, Independent Director
- Wendy Perrow, Independent Director
How do I buy Bioanalytical Systems stock?
Shares of Bioanalytical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Bioanalytical Systems' stock price today?
One share of Bioanalytical Systems stock can currently be purchased for approximately $1.82.
MarketBeat Community Rating for Bioanalytical Systems (NASDAQ BASI)MarketBeat's community ratings are surveys of what our community members think about Bioanalytical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Bioanalytical Systems (NASDAQ:BASI) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Consensus Price Target History for Bioanalytical Systems (NASDAQ:BASI)
Analysts' Ratings History for Bioanalytical Systems (NASDAQ:BASI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Bioanalytical Systems (NASDAQ:BASI)Earnings History by Quarter for Bioanalytical Systems (NASDAQ BASI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 12/20/2017 | | | | | | | N/A |  |
| 8/14/2017 | Q3 2017 | | $0.03 | | $5.84 million | View | N/A | |
| 5/15/2017 | Q2 2017 | | $0.05 | | $6.36 million | View | N/A | |
| 8/11/2016 | Q316 | | ($0.05) | $6.15 million | $5.05 million | View | Listen | |
| 5/12/2016 | Q216 | | ($0.03) | $5.73 million | $5.34 million | View | Listen | |
| 2/16/2016 | Q116 | | ($0.06) | $5.95 million | $4.90 million | View | Listen | |
| 12/17/2015 | Q415 | | ($0.09) | $6.42 million | $4.98 million | View | Listen | |
| 8/13/2015 | Q315 | | $0.16 | $6.03 million | $6.15 million | View | Listen | |
| 5/14/2015 | Q215 | | ($0.01) | $5.92 million | $5.73 million | View | Listen | |
| 2/12/2015 | Q115 | | $0.01 | $6.22 million | $5.85 million | View | N/A | |
| 12/22/2014 | Q414 | | ($0.02) | | $6.42 million | View | N/A | |
| 8/14/2014 | Q314 | | $0.02 | $5.60 million | $6.03 million | View | N/A | |
| 5/15/2014 | Q2 | | ($0.03) | $5.16 million | $5.91 million | View | Listen | |
| 2/13/2014 | Q114 | | $0.04 | $5.80 million | $6.22 million | View | N/A | |
| 12/24/2013 | Q4 13 | | $0.03 | $6.54 million | $5.51 million | View | N/A | |
| 10/18/2013 | Q313 | $0.01 | $0.07 | $5.65 million | $5.60 million | View | N/A | |
| 5/15/2013 | Q2 2013 | $0.01 | ($0.02) | $5.74 million | $5.16 million | View | Listen | |
| 2/14/2013 | Q1 2013 | ($0.03) | $0.02 | $6.65 million | $5.80 million | View | Listen | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Bioanalytical Systems (NASDAQ:BASI)Current Year EPS Consensus Estimate: $0.01 EPS
Next Year EPS Consensus Estimate: $0.08 EPS
Dividend History for Bioanalytical Systems (NASDAQ:BASI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Bioanalytical Systems (NASDAQ:BASI)Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 4.06%
Insider Trades by Quarter for Bioanalytical Systems (NASDAQ:BASI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/8/2017 | R Matthew Neff | Director | Buy | 5,000 | $1.50 | $7,500.00 | |
| 8/18/2017 | R Matthew Neff | Director | Buy | 5,000 | $1.70 | $8,500.00 | |
| 5/27/2016 | Connie Leigh Dougherty | VP | Buy | 423 | $0.92 | $389.16 | |
| 5/23/2016 | Connie Leigh Dougherty | VP | Buy | 96 | $0.92 | $88.32 | |
| 5/19/2016 | Connie Leigh Dougherty | VP | Buy | 1,655 | $0.92 | $1,522.60 | |
| 2/29/2016 | Jacqueline M Lemke | CEO | Buy | 10,000 | $1.18 | $11,800.00 | |
| 9/14/2015 | Philip A Downing | VP | Buy | 3,000 | $1.73 | $5,190.00 | |
| 2/27/2015 | Jacqueline M Lemke | CEO | Buy | 10,000 | $2.04 | $20,400.00 | |
| 6/13/2014 | John P Devine | VP | Sell | 3,130 | $2.64 | $8,263.20 | |
| 8/17/2012 | David L Omachinski | Director | Buy | 10,000 | $1.26 | $12,600.00 | |
| 8/17/2012 | Jacqueline M Lemke | CEO | Buy | 20,000 | $1.26 | $25,200.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Bioanalytical Systems (NASDAQ:BASI)
Latest Headlines for Bioanalytical Systems (NASDAQ:BASI)
| Source: |
|
| Date | Headline |
|---|
 | Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of in Vivo Products and Services
finance.yahoo.com - October 3 at 4:06 PM |
| Bioanalytical Systems Inc (BASI): Is Healthcare An Attractive Sector Play?
finance.yahoo.com - September 22 at 3:18 PM |
| BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology
finance.yahoo.com - September 6 at 4:15 PM |
| Featured Company News - Myriad Genetics' EndoPredict Receives Positive Coverage Decisions from Palmetto and Anthem
finance.yahoo.com - August 22 at 10:03 PM |
| Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 4:58 PM |
| Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 4:58 PM |
 | Bioanalytical Systems, Inc. (BASI) Releases Earnings Results
www.americanbankingnews.com - August 15 at 9:41 AM |
| BASi Reports Continued Profitability Improvement in Third Quarter
finance.yahoo.com - August 14 at 4:44 PM |
| BASi Announces Election of R. Matthew Neff to the Board of Directors
finance.yahoo.com - August 3 at 5:46 PM |
| Bioanalytical Systems, Inc. (NASDAQ:BASI) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - August 2 at 7:20 AM |
| BASi Signs Reseller Agreement With LABEX of MA for Refurbished Culex(R) Automated Blood Sampling Systems
finance.yahoo.com - July 31 at 4:27 PM |
 | Bioanalytical Systems, Inc.: BASi Names Dr. Gregory C. Davis to Board of Directors
www.finanznachrichten.de - June 20 at 4:31 PM |
 | BRIEF-BASI reports Q2 earnings per share $0.05
www.reuters.com - May 17 at 12:06 PM |
| Q1 2017 Bioanalytical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - February 14 at 8:27 PM |
 | BASi Reports First Quarter Results
us.rd.yahoo.com - February 14 at 8:27 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
biz.yahoo.com - January 17 at 4:32 PM |
| Q4 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - December 22 at 3:51 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
biz.yahoo.com - December 22 at 3:51 PM |
| Bioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET today
biz.yahoo.com - December 22 at 3:51 PM |
| Bioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET today
biz.yahoo.com - December 22 at 3:51 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
biz.yahoo.com - December 7 at 4:26 PM |
| BRIEF-Basi Q3 loss per share $0.05
www.reuters.com - August 12 at 12:20 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure
biz.yahoo.com - August 4 at 3:50 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
biz.yahoo.com - July 22 at 3:12 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - July 6 at 1:19 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - July 6 at 1:19 PM |
| Q2 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open
biz.yahoo.com - May 12 at 7:07 AM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
biz.yahoo.com - May 4 at 1:16 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - March 16 at 3:52 PM |
Bioanalytical Systems (BASI) Chart for Thursday, October, 19, 2017
